---
title: Clario vs MMS Holdings
slug_a: clario
slug_b: mmsholdings
site: cro
review_signal_gate: closed
canonical_path: /compare/clario/mmsholdings
generated_by: BioBM Editorial AI
---

# Clario vs MMS Holdings

This comparison is auto-generated by BioBM Editorial AI and intended as an evidence-oriented side-by-side reference.

## Company A

Clario (clario) is listed for cro. Clario provides comprehensive clinical trial endpoint solutions spanning cardiac safety, eCOA, medical imaging, respiratory, and precision motion analysis, supporting approximately 70% of FDA and EMA novel drug approvals over the past decade.

Services: 16. Modalities: 4. Indications: 12. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (16).

Review summary: Review summary withheld until site-level review gate opens.

## Company B

MMS Holdings (mmsholdings) is listed for cro. Data-focused CRO providing full-spectrum biometrics, regulatory submissions, safety & risk management, and therapeutic expertise across oncology, CNS, rare diseases, and psychedelics. Named Best Specialist CRO at the Scrip Awards with zero refusals to file on 50+ marketing applications in five years.

Services: 14. Modalities: 5. Indications: 5. Locations: 1. Certifications: 0. Directory-wide review aggregates for this site are withheld until the review signal gate opens. The strongest documented coverage currently appears in services (14).

Review summary: Review summary withheld until site-level review gate opens.